Direct oral anticoagulant plasma levels’ striking increase in severe COVID‐19 respiratory syndrome patients treated with antiviral agents: The Cremona experience

Background Antiviral drugs are administered in patients with severe COVID‐19 respiratory syndrome, including those treated with direct oral anticoagulants (DOACs). Concomitant administration of antiviral agents has the potential to increase their plasma concentration. A series of patients managed in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of thrombosis and haemostasis 2020-06, Vol.18 (6), p.1320-1323
Hauptverfasser: Testa, Sophie, Prandoni, Paolo, Paoletti, Oriana, Morandini, Rossella, Tala, Maurizio, Dellanoce, Claudia, Giorgi‐Pierfranceschi, Matteo, Betti, Monia, Battista Danzi, Gian, Pan, Angelo, Palareti, Gualtiero
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!